Charles Piller, an award-winning investigative correspondent for Science Magazine and nine-time Pulitzer Prize nominee, dives into the troubling manipulation of Alzheimer's research. He discusses the dangers of fraudulent studies and highlights the case of the drug Simufilum. Piller examines how misinformation has skewed research funding and emphasizes the importance of lifestyle choices in reducing Alzheimer’s risk. He also critiques the financial ties between advocacy groups and pharma, advocating for transparency and integrity in scientific research.

Charles Piller, an investigative journalist for Science Magazine and author of "Doctored," exposes the dark side of Alzheimer's research. He reveals how fraudulent studies, like one that cemented the amyloid hypothesis, misled the field for decades. Piller discusses NIH funding incentives encouraging flawed research and the heroic roles of whistleblowers uncovering manipulation. He underscores the urgent need for transparency while highlighting promising new avenues in treatment, such as viral research and GLP-1 inhibitors, instilling hope for patients and families alike.

Charles Piller, an investigative journalist for Science magazine and author of 'Doctored,' delves into the troubling landscape of Alzheimer’s research. He reveals alarming instances of fraud that have skewed studies and limited progress. Piller discusses the flawed amyloid hypothesis, potential misconduct in drug approvals, and calls for greater transparency in scientific practices. He highlights the emotional toll of Alzheimer's on patients and families, emphasizing the urgent need for accountability to unlock new treatment avenues.